NASDAQ:ADAP

Adaptimmune Therapeutics PLC

Market:

NASDAQ

Market Cap:

$1.46 billion

Price

11.25 USD

Change

-1.23%

52 weeks high

13.39

52 weeks low

0.71

In brief

Adaptimmune is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapy products for cancer patients.

In brief Deep dive Research Latest news Insight Interviews